Drug Type Monoclonal antibody |
Synonyms AK 001, AK001 |
Target |
Mechanism Siglec-8 inhibitors(Sialic acid-binding Ig-like lectin 8 inhibitors), Immunomodulators |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 1 | US | 01 Sep 2015 | |
Hypersensitivity | Phase 1 | US | - |
Phase 2 | 40 | (25 mg AK001) | mdcvwaozho(sphoyruneg) = kldoswswhe vbyawpnlbx (xtkpjbcpig, rlesvkhibv - evfmdgzdsp) View more | - | 28 Dec 2020 | ||
(250 mg AK001) | mdcvwaozho(sphoyruneg) = ipmonkvoss vbyawpnlbx (xtkpjbcpig, bcjwygbcoe - uilmksksho) View more |